259 related articles for article (PubMed ID: 26816087)
1. Jumonji histone demethylases as emerging therapeutic targets.
Park SY; Park JW; Chun YS
Pharmacol Res; 2016 Mar; 105():146-51. PubMed ID: 26816087
[TBL] [Abstract][Full Text] [Related]
2. Evolution and conservation of JmjC domain proteins in the green lineage.
Huang Y; Chen D; Liu C; Shen W; Ruan Y
Mol Genet Genomics; 2016 Feb; 291(1):33-49. PubMed ID: 26152513
[TBL] [Abstract][Full Text] [Related]
3. Structure-function relationships in KDM7 histone demethylases.
Chaturvedi SS; Ramanan R; Waheed SO; Karabencheva-Christova TG; Christov CZ
Adv Protein Chem Struct Biol; 2019; 117():113-125. PubMed ID: 31564306
[TBL] [Abstract][Full Text] [Related]
4. The Jumonji gene family in Crassostrea gigas suggests evolutionary conservation of Jmj-C histone demethylases orthologues in the oyster gametogenesis and development.
Fellous A; Favrel P; Guo X; Riviere G
Gene; 2014 Mar; 538(1):164-75. PubMed ID: 24406622
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15.
Duan L; Perez RE; Calhoun S; Maki CG
Cancer Biol Ther; 2022 Dec; 23(1):65-75. PubMed ID: 35100078
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in catalysis and inhibition of the Jumonji histone demethylases.
Sarah L; Fujimori DG
Curr Opin Struct Biol; 2023 Dec; 83():102707. PubMed ID: 37832177
[TBL] [Abstract][Full Text] [Related]
7. The Jumonji family: past, present and future of histone demethylases in cancer.
Franci G; Ciotta A; Altucci L
Biomol Concepts; 2014 Jun; 5(3):209-24. PubMed ID: 25372754
[TBL] [Abstract][Full Text] [Related]
8. JMJD3 as an epigenetic regulator in development and disease.
Burchfield JS; Li Q; Wang HY; Wang RF
Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
[TBL] [Abstract][Full Text] [Related]
9. The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies.
Staehle HF; Pahl HL; Jutzi JS
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944554
[TBL] [Abstract][Full Text] [Related]
10. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
11. JARID1 Histone Demethylases: Emerging Targets in Cancer.
Harmeyer KM; Facompre ND; Herlyn M; Basu D
Trends Cancer; 2017 Oct; 3(10):713-725. PubMed ID: 28958389
[TBL] [Abstract][Full Text] [Related]
12. KDM7 Demethylases: Regulation, Function and Therapeutic Targeting.
Shao P; Liu Q; Qi HH
Adv Exp Med Biol; 2023; 1433():167-184. PubMed ID: 37751140
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic gene regulation by plant Jumonji group of histone demethylase.
Chen X; Hu Y; Zhou DX
Biochim Biophys Acta; 2011 Aug; 1809(8):421-6. PubMed ID: 21419882
[TBL] [Abstract][Full Text] [Related]
14. The role of the histone demethylase KDM4A in cancer.
Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
[TBL] [Abstract][Full Text] [Related]
15. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation by histone demethylases in hypoxia.
Hancock RL; Dunne K; Walport LJ; Flashman E; Kawamura A
Epigenomics; 2015 Aug; 7(5):791-811. PubMed ID: 25832587
[TBL] [Abstract][Full Text] [Related]
17. Purification, Biochemical Analysis, and Structure Determination of JmjC Lysine Demethylases.
Krishnan S; Trievel RC
Methods Enzymol; 2016; 573():279-301. PubMed ID: 27372758
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of histone lysine demethylases in prostate cancer.
Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
[TBL] [Abstract][Full Text] [Related]
19. The role and prospect of lysine-specific demethylases in cancer chemoresistance.
Song YQ; Yang GJ; Ma DL; Wang W; Leung CH
Med Res Rev; 2023 Sep; 43(5):1438-1469. PubMed ID: 37012609
[TBL] [Abstract][Full Text] [Related]
20. Histone lysine demethylases in breast cancer.
Paolicchi E; Crea F; Farrar WL; Green JE; Danesi R
Crit Rev Oncol Hematol; 2013 May; 86(2):97-103. PubMed ID: 23266085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
